A detailed history of State Of Alaska, Department Of Revenue transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 76,130 shares of TGTX stock, worth $2.25 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
76,130
Holding current value
$2.25 Million
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$17.21 - $25.28 $1.31 Million - $1.92 Million
76,130 New
76,130 $1.78 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.